Cite Filings / APRE / 0001558370-22-009946

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Aprea Therapeutics, Inc. Filed 2022-06-10 Acc 0001558370-22-009946

Documents 1

DEF 14A Proxy Statement , apre-20220728xdef14a.htm

Around this filing

2022-10-26 DEF 14A Proxy Statement
2022-06-10 DEF 14A Proxy Statement
2022-06-07 4 Chairman & CEO gave up 65,770 shares (to pay taxes)
2022-06-07 4 SVP, Chief Financial Officer gave up 35,284 shares (to pay taxes)
2022-06-07 4 SVP, Chief Operating Officer gave up 8,390 shares (to pay taxes)
2022-06-07 4 SVP, Chief Medical Officer gave up 32,667 shares (to pay taxes)
2021-04-28 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading apre-20220728xdef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…